Freudenberg Medical, a global developer and manufacturer of finished medical devices and subassemblies, components, and minimally invasive solutions for the medical device industry, announced several new options for medical device companies looking to accelerate time to market. The new hemostasis valve family adds the innovative HyperSeal and CertuSeal valves to the well-received FlexSeal valve launched last year. Hemostasis valves are used to minimize blood loss and can facilitate minimally invasive, catheter-based medical procedures. Also being introduced is the new HyperSeal Introducer Sheath with Hydrophilic Coating which joins the FlexSeal Introducer Sheath as a white label device solution for large bore procedures.
 
Introduced at the Transcatheter Cardiovascular Therapeutics Conference (TCT) in Denver, Colorado, the annual scientific symposium of the Cardiovascular Research Foundation, these sophisticated hemostasis valves can be directly incorporated into therapeutic catheter development projects in order to provide new design options, shorten development time, and lower costs.
 
“Freudenberg Medical’s hemostasis valves provide a wide range of innovative features designed to greatly improve hemostasis and procedural performance when integrated into next generation catheters and delivery systems,” said Bernie Kaeferlein, director of portfolio management at Freudenberg Medical. “As a partner for innovation, we are committed to proactively addressing unmet clinical needs and offering our medical device customers a growing portfolio of finished device, design, and process solutions to help improve efficiency and accelerate their time to market.”
 
Freudenberg Medical’s portfolio of medical device solutions also includes the versatile Composer Deflectable Catheter Handle Platform.